Appointment Type |
Department |
Division |
Rank |
Primary |
Medicine |
Med - Nephrology |
Assistant Professor |
Center |
Comprehensive Diabetes Center |
Comprehensive Diabetes Center |
Assistant Professor |
Center |
General Clinical Research Center |
Nephrology Research & Training Center |
Assistant Professor |
|
Publication |
PUBMEDID |
Wada T, Pippin JW, Marshall CB, Griffin SV, Shankland SJ. Dexamethasone Prevents Podocyte Apoptosis Induced by Puromycin Aminonucleoside: Role of p53 and Bcl-2-related Family Proteins. J Am Soc Nephrol 2005; 16: 2615-2625.
|
15987750 |
Marshall CB, Shankland SJ. Cell Cycle and Glomerular Disease: A Minireview. Nephron Exp Nephrol 2006; 102 (2): e39-e48. Epub 2005 Sep 21.
|
16179806 |
Marshall CB, Pippin JW, Krofft RD, Shankland SJ. Puromycin Aminonucleoside Induces Oxidant-Dependent DNA Damage In Vitro and In Vivo. Kidney International, 2006; 70 (11): 1962-1973. |
17035936 |
Marshall CB, Shankland SJ. Cell Cycle Regulatory Proteins in Podocyte Health and Disease. Nephron Exp Nephrol, 2007; 106 (2): e51-9. Epub 2007 Jun 6.
|
17570940 |
Pippin JW, Brinkkoetter PT, Cormack-Aboud FC, Durvasula RV, Hauser PV, Kowalewska J, Krofft RD, Logar CM, Marshall CB, Ohse T, Shankland SJ. Inducible rodent models of acquired podocyte diseases. Am J Physiol Renal Physiol. 2009 Feb; 296 (2): F213-29.
|
18784259 |
Ohse T, Vaughan MR, Kopp JB, Krofft RD, Marshall CB, Chang AM, Hudkins KL, Alpers, CE, Pippin JW, Shankland SJ. De novo Expression of Podocyte Proteins in Parietal Epithelial Cells During Experimental Glomerular Disease. Am J Physiol Renal Physiol. Epub 2009 Dec 09.
|
20007346 |
Marshall CB, Krofft RD, Pippin JW, Shankland SJ. The CDK-inhibitor p21 is Pro-survival in Adriamycin-Induced Podocyte Injury, in vitro and in vivo. Am J Physiol Renal Physiol. Epub 2010 Feb 03.
|
20130121 |
Marshall CB, Krofft RD, Blonski MJ, Kowalewska J, Logar CM, Pippin JW, Kim F, Feil R, Alpers CE, Shankland SJ. The Role of Smooth Muscle Protein SM22-alpha; in Glomerular Epithelial Cell Injury. Am J Physiol Renal Physiol. Epub 2011 Feb 02.
|
21289056 |
Chugh SS, Macé C, Clement LC, Del Nogal Avila M, and Marshall CB. Angiopoietin-like-4 based therapeutics for proteinuria and kidney disease. Frontiers in Pharmacology. Epub 2014 Feb 14. |
24611049 |
Clement LC, Macé C, Del Nogal Avila M, Marshall CB, and Chugh SS. The proteinuria – hypertriglyceridemia connection as a basis for novel therapeutics for nephrotic syndrome. Translational Research. 2014 Jun 18. pii: S1931-5244. |
25005737 |
Del Nogal-Avila M, Donoro-Blazquez H, Saha M, Marshall CB, Clement LC, Macé C, and Chugh SS. Novel therapeutic approaches for chronic kidney disease due to glomerular disorders. Am J Physiol Renal Physiol 2016; 311: F63-65. |
27147672 |
Marshall CB. Invited Review: Re-thinking Glomerular Basement Membrane Thickening in Diabetic Nephropathy—Adaptive or Pathogenic? Am J Physiol Renal Physiol 2016 Aug 31. [Epub ahead of print]. |
27582102 |
|
|